Target intelligence / Profile preview

N-methyl-D-aspartate receptor ion channel pore (NMDAR ion channel pore)

Target
NMDAR ion channel pore
Molecular classification
Ion channel, Glutamate receptor, Ligand-gated ion channel, Ionotropic glutamate receptor
01

Overview

The N-methyl-D-aspartate (NMDA) receptor ion channel pore is a specialized transmembrane structure within the NMDA receptor complex that regulates the flow of cations, particularly calcium, into neurons [2, 4]. It functions as a ligand-gated and voltage-dependent channel, requiring both glutamate binding and membrane depolarization to remove a magnesium ion block [1, 12]. This unique mechanism allows the pore to act as a coincidence detector, a process fundamental to synaptic plasticity, learning, and memory [2, 7]. Pathological overactivation of the pore leads to excessive calcium influx, causing excitotoxicity and neuronal death in conditions like Alzheimer's disease and stroke [3, 14]. Conversely, hypofunction of the receptor is associated with the pathophysiology of schizophrenia and cognitive deficits [5, 15]. The pore is a major therapeutic target for uncompetitive antagonists, such as memantine and ketamine, which bind within the channel to modulate its activity [6, 17]. While these drugs are effective for treating dementia and depression, they can also induce dissociative and psychotomimetic side effects by interfering with normal neurotransmission [2, 15].

Other names
NMDA receptor poreNMDA receptor ionophoreNMDAR channelPCP binding siteNMDA receptor-ionophore complex
02

Mechanism of action

Uncompetitive antagonism through voltage-dependent pore blockade

03

Biological functions

Synaptic plasticityCalcium signalingLearning and memoryExcitatory neurotransmissionLong-term potentiation (LTP)Long-term depression (LTD)
04

Disease associations

Alzheimer's diseaseMajor depressive disorderSchizophreniaEpilepsyNeuropathic painStrokeHuntington's diseaseParkinson's diseaseAnti-NMDA receptor encephalitis
05

Safety considerations

Dissociative effectsPsychotomimetic symptoms (hallucinations)Cognitive impairmentPotential for substance abuseCardiovascular effects (hypertension, tachycardia)Sedation
06

Interacting drugs

Ketamine

7 more in the full profile.

07

Biomarkers

CSF glutamate levelsPET imaging of open NMDA channels (e.g., [18F]GE-179)EEG gamma oscillationsSynaptic density (SV2A PET)

Beyond the preview

Go deeper on N-methyl-D-aspartate receptor ion channel pore (NMDAR ion channel pore).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on N-methyl-D-aspartate receptor ion channel pore (NMDAR ion channel pore).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call